Publicaciones en colaboración con investigadores/as de Hospital Universitario de la Princesa (17)

2024

  1. PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial

    European urology oncology, Vol. 7, Núm. 3, pp. 462-468

2023

  1. ESTRO ACROP consensus recommendation on the target volume definition for radiation therapy of macroscopic prostate cancer recurrences after radical prostatectomy

    Clinical and Translational Radiation Oncology, Vol. 43

  2. ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer

    Clinical and Translational Radiation Oncology, Vol. 41

2022

  1. Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial

    Radiotherapy and Oncology, Vol. 172, pp. 1-9

2021

  1. The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases

    European Urology Focus

2020

  1. PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): A study protocol for a randomized controlled phase II trial

    BMC Cancer, Vol. 20, Núm. 1

2019

  1. Consensus on management of castration-resistant prostate cancer on behalf of the Urological Tumours Working Group (URONCOR) of the Spanish Society of Radiation Oncology

    Clinical and Translational Oncology, Vol. 21, Núm. 4, pp. 420-432

  2. Impact of rectum and bladder anatomy in intrafractional prostate motion during hypofractionated radiation therapy

    Clinical and Translational Oncology, Vol. 21, Núm. 5, pp. 607-614

  3. Long-term Outcomes and Patterns of Failure Following Trimodality Treatment With Bladder Preservation for Invasive Bladder Cancer

    Urology, Vol. 124, pp. 183-190

  4. author reply

    Urology

2017

  1. Products based on olive oil, betaine, and xylitol in the post-radiotherapy xerostomia

    Reports of Practical Oncology and Radiotherapy, Vol. 22, Núm. 1, pp. 71-76

  2. Reduced late urinary toxicity with high-dose intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer

    Clinical and Translational Oncology, Vol. 19, Núm. 9, pp. 1161-1167

2016

  1. Corrigendum to "Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance". [Rep. Pract. Oncol. Radiother. 20 (2015) 259-272]

    Reports of Practical Oncology and Radiotherapy

2015

  1. Bystander effects and radiotherapy

    Reports of Practical Oncology and Radiotherapy, Vol. 20, Núm. 1, pp. 12-21

  2. Dermatofibrosarcoma protuberans with lung metastasis requiring pneumonectomy

    Rare Tumors, Vol. 7, Núm. 4, pp. 166-168

  3. Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance

    Reports of Practical Oncology and Radiotherapy, Vol. 20, Núm. 4, pp. 259-272

2012

  1. Cerca de las Antípodas. Análisis comparativo de los sistemas sanitarios español y australiano

    Medicina Preventiva, Vol. 18, Núm. 1, pp. 36-40